Journal
AUSTRALASIAN JOURNAL OF DERMATOLOGY
Volume 47, Issue 4, Pages 231-236Publisher
WILEY
DOI: 10.1111/j.1440-0960.2006.00287.x
Keywords
atypical fibroxanthoma; basal cell carcinoma; chronic lymphocytic leukaemia; Kaposi sarcoma; melanoma; Merkel cell carcinoma; non-melanoma skin cancer; prognosis; squamous cell carcinoma; treatment
Categories
Ask authors/readers for more resources
There is a significant association between non-Hodgkin lymphoma, including chronic lymphocytic leukaemia, and both melanoma and non-melanoma skin cancer. This review highlights the existing data on the phenomenon of accelerated skin cancer in patients with non-Hodgkin lymphoma and specifically chronic lymphocytic leukaemia. The outcomes of patients with non-Hodgkin lymphoma (including chronic lymphocytic leukaemia) and non-melanoma skin cancer are worse than in patients without concomitant lymphoreticular malignancy, as shown by increased rates of local recurrence, regional metastasis and death. Pathogenic factors may be common between non-Hodgkin lymphoma and chronic lymphocytic leukaemia and skin cancer. The treatment of skin cancer in patients with non-Hodgkin lymphoma must factor in the worse prognosis and adapt standard therapeutic approaches to minimize the risk of metastasis and death. Preventive strategies and early detection are paramount in this high-risk population.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available